Potomac, MD, United States of America

Tsanyang Liang


 

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Tsanyang Liang

Introduction

Tsanyang Liang is a notable inventor based in Potomac, MD (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of antiviral agents. His work focuses on creating compounds that can be utilized in the treatment of various viral infections and cancers.

Latest Patents

Tsanyang Liang holds a patent for "Heterocyclic compounds and methods of use thereof." This patent discloses compounds of formula (I), formula (II), and formula (III), wherein Ar, R, A, and X are defined in the specification. These compounds are recognized as antiviral agents and are intended for use in treating viral infections, such as hepatitis C. Additionally, they are contemplated for use in treating or preventing cancers.

Career Highlights

Throughout his career, Tsanyang Liang has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and the University of Kansas Medical Center Research Institute. His experience in these institutions has allowed him to contribute to significant advancements in medical research.

Collaborations

Tsanyang Liang has collaborated with esteemed colleagues, including Zongyi Hu and Juan Jose Marugan. These partnerships have further enhanced his research and development efforts in the field of antiviral compounds.

Conclusion

In summary, Tsanyang Liang is an accomplished inventor whose work in developing antiviral agents has the potential to impact the treatment of viral infections and cancers significantly. His contributions to medicinal chemistry are noteworthy and reflect his dedication to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…